telehealth services new jersey compounded glp-1 receptor agonist weight loss Gala Claims Evaluated: The Most Trusted GLP1 Tirzepetide Prescription Treatment & Tracker Provider FDA CRACKDOWN ESCALATES: 30 telehealth
Description
Wegovy : Average weight loss of 13.7% (33.1 lbs) in similar studies
Yes-Zepbound and Mounjaro contain the same active ingredient (tirzepatide) but are FDA approved for different conditions: Zepbound for weight management and Mounjaro for type 2 diabetes

Dosage adjustments may be necessary

As digital healthcare becomes more widespread among providers, patients can anticipate a broader range of remote services, ensuring that safe and effective treatment is available, regardless of their location

Hair loss concerns have emerged in community discussions, though clinical trial data did not identify this as a statistically significant adverse event
Liver fat reduction by dose At the 1mg dose, liver fat decreased by 42.9% at 24 weeks
